{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:31:44Z","timestamp":1780659104356,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"DOI":"10.7759\/cureus.42786","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T09:43:44Z","timestamp":1690883024000},"source":"Crossref","is-referenced-by-count":1,"title":["Inflammatory Bowel Sugar Disease: A Pause From New Pharmacological Agents and an Embrace of Natural Therapy"],"prefix":"10.7759","author":[{"given":"Anas","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Begg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawada","family":"Tarhuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"N. Fotso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra R","family":"Sanivarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abishek","family":"Latha Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Sadagopan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen L","year":"2018","unstructured":"Chen L, Deng H, Cui H, et al.. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018, 9:7204-18. 10.18632\/oncotarget.23208","journal-title":"Oncotarget"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.199679","article-title":"New IBD genetics: common pathways with other diseases","volume":"60","author":"Lees CW","year":"2011","unstructured":"Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: common pathways with other diseases. Gut. 2011, 60:1739-53. 10.1136\/gut.2009.199679","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01483-4","article-title":"Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10(-\/-) mouse model of inflammatory bowel disease","volume":"11","author":"Armstrong H","year":"2023","unstructured":"Armstrong H, Rahbari M, Park H, et al.. Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10(-\/-) mouse model of inflammatory bowel disease. Microbiome. 2023, 11:39. 10.1186\/s40168-023-01483-4","journal-title":"Microbiome"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen HK","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB, et al.. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016, 535:376-81. 10.1038\/nature18646","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074957","article-title":"Bacterial community mapping of the mouse gastrointestinal tract","volume":"8","author":"Gu S","year":"2013","unstructured":"Gu S, Chen D, Zhang JN, et al.. Bacterial community mapping of the mouse gastrointestinal tract. PLoS One. 2013, 8:e74957. 10.1371\/journal.pone.0074957","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4236\/aid.2023.132021","article-title":"Hepatitis: a case of infectious and autoimmune hepatitis occurring with neurosyphilis","volume":"13","author":"Rajkumar K","year":"2023","unstructured":"Rajkumar K, Mahmoud A, Mekheal N, Abdalla M, Grossman M, Baddoura W. Hepatitis: a case of infectious and autoimmune hepatitis occurring with neurosyphilis. Adv Infect Dis. 2023, 13:10.4236\/aid.2023.132021","journal-title":"Adv Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4236\/crcm.2023.124015","article-title":"Cholangiocarcinoma, Primary Sclerosing Cholangitis, or IgG4-Sclerosing Cholangitis: Similar Presentations with Different Managements","volume":"12","author":"Mahmoud A","year":"2023","unstructured":"Mahmoud A, Mohamed A, Alyassin N, Grossman M, Cavanagh Y . Cholangiocarcinoma, Primary Sclerosing Cholangitis, or IgG4-Sclerosing Cholangitis: Similar Presentations with Different Managements. Case Rep Clin Med. 2023, 12:10.4236\/crcm.2023.124015","journal-title":"Case Rep Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.10.012","article-title":"Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches","volume":"152","author":"Sartor RB","year":"2017","unstructured":"Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology. 2017, 152:327-339.e4. 10.1053\/j.gastro.2016.10.012","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu15020259","article-title":"Gut microbiota and time-restricted feeding\/eating: a targeted biomarker and approach in precision nutrition","volume":"15","author":"Zeb F","year":"2023","unstructured":"Zeb F, Osaili T, Obaid RS, et al.. Gut microbiota and time-restricted feeding\/eating: a targeted biomarker and approach in precision nutrition. Nutrients. 2023, 15:259. 10.3390\/nu15020259","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.944387","article-title":"Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: a systematic review and meta-analysis","volume":"13","author":"Zeng L","year":"2022","unstructured":"Zeng L, Deng Y, Yang K, Chen J, He Q, Chen H. Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: a systematic review and meta-analysis. Front Immunol. 2022, 13:944387. 10.3389\/fimmu.2022.944387","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i19.3565","article-title":"Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease: the first report","volume":"23","author":"He Z","year":"2017","unstructured":"He Z, Cui BT, Zhang T, Li P, Long CY, Ji GZ, Zhang FM. Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease: the first report. World J Gastroenterol. 2017, 23:3565-8. 10.3748\/wjg.v23.i19.3565","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/bs.accb.2015.08.002","article-title":"Human milk oligosaccharides (HMOS): structure, function, and enzyme-catalyzed synthesis","volume":"72","author":"Chen X","year":"2015","unstructured":"Chen X. Human milk oligosaccharides (HMOS): structure, function, and enzyme-catalyzed synthesis. Adv Carbohydr Chem Biochem. 2015, 72:113-90. 10.1016\/bs.accb.2015.08.002","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2010.118","article-title":"Dominant and diet-responsive groups of bacteria within the human colonic microbiota","volume":"5","author":"Walker AW","year":"2011","unstructured":"Walker AW, Ince J, Duncan SH, et al.. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5:220-30. 10.1038\/ismej.2010.118","journal-title":"ISME J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nature16504","article-title":"Diet-induced extinctions in the gut microbiota compound over generations","volume":"529","author":"Sonnenburg ED","year":"2016","unstructured":"Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature. 2016, 529:212-5. 10.1038\/nature16504","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i14.2078","article-title":"Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives","volume":"29","author":"Roy S","year":"2023","unstructured":"Roy S, Dhaneshwar S. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives. World J Gastroenterol. 2023, 29:2078-100. 10.3748\/wjg.v29.i14.2078","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/foods12081628","article-title":"Screening, identification and physiological characteristics of Lactobacillus rhamnosus M3 (1) against intestinal inflammation","volume":"12","author":"Jiang J","year":"2023","unstructured":"Jiang J, Li K, Wang Y, Wu Z, Ma H, Zheng S, Li Z. Screening, identification and physiological characteristics of Lactobacillus rhamnosus M3 (1) against intestinal inflammation. Foods. 2023, 12:1628. 10.3390\/foods12081628","journal-title":"Foods"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.938086","article-title":"Aleukemic acute promyelocytic leukemia: how concomitant HIV, hepatitis C, and chronic alcohol use disorder may have hidden an underlying malignancy","volume":"24","author":"Mahmoud A","year":"2023","unstructured":"Mahmoud A, Ghrewati M, Kania B, Naseer M, Kapoor A, Michael P. Aleukemic acute promyelocytic leukemia: how concomitant HIV, hepatitis C, and chronic alcohol use disorder may have hidden an underlying malignancy. Am J Case Rep. 2023, 24:e938086. 10.12659\/AJCR.938086","journal-title":"Am J Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082189","article-title":"Postbiotics-a step beyond pre- and probiotics","volume":"12","author":"\u017b\u00f3\u0142kiewicz J","year":"2020","unstructured":"\u017b\u00f3\u0142kiewicz J, Marzec A, Ruszczy\u0144ski M, Feleszko W. Postbiotics-a step beyond pre- and probiotics. Nutrients. 2020, 12:2189. 10.3390\/nu12082189","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i48.10532","article-title":"Effects of Saccharomyces cerevisiae or boulardii yeasts on acute stress induced intestinal dysmotility","volume":"22","author":"West C","year":"2016","unstructured":"West C, Stanisz AM, Wong A, Kunze WA. Effects of Saccharomyces cerevisiae or boulardii yeasts on acute stress induced intestinal dysmotility. World J Gastroenterol. 2016, 22:10532-44. 10.3748\/wjg.v22.i48.10532","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5551\/jat.4812","article-title":"Kefiran reduces atherosclerosis in rabbits fed a high cholesterol diet","volume":"17","author":"Uchida M","year":"2010","unstructured":"Uchida M, Ishii I, Inoue C, et al.. Kefiran reduces atherosclerosis in rabbits fed a high cholesterol diet. J Atheroscler Thromb. 2010, 17:980-8. 10.5551\/jat.4812","journal-title":"J Atheroscler Thromb"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2010.07.050","article-title":"Naturally occurring 2-substituted (1,3)-beta-D-glucan producing Lactobacillus suebicus and Pediococcus parvulus strains with potential utility in the production of functional foods","volume":"101","author":"Garai-Ibabe G","year":"2010","unstructured":"Garai-Ibabe G, Due\u00f1as MT, Irastorza A, et al.. Naturally occurring 2-substituted (1,3)-beta-D-glucan producing Lactobacillus suebicus and Pediococcus parvulus strains with potential utility in the production of functional foods. Bioresour Technol. 2010, 101:9254-63. 10.1016\/j.biortech.2010.07.050","journal-title":"Bioresour Technol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.07.023","article-title":"Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner","volume":"51","author":"Lee C","year":"2017","unstructured":"Lee C, Kim BG, Kim JH, Chun J, Im JP, Kim JS. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. Int Immunopharmacol. 2017, 51:47-56. 10.1016\/j.intimp.2017.07.023","journal-title":"Int Immunopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s13197-011-0244-0","article-title":"Antioxidative potential of folate producing probiotic Lactobacillus helveticus CD6","volume":"50","author":"Ahire JJ","year":"2013","unstructured":"Ahire JJ, Mokashe NU, Patil HJ, Chaudhari BL. Antioxidative potential of folate producing probiotic Lactobacillus helveticus CD6. J Food Sci Technol. 2013, 50:26-34. 10.1007\/s13197-011-0244-0","journal-title":"J Food Sci Technol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/09637480600968735","article-title":"Plasma cobalamin and folate and their metabolic markers methylmalonic acid and total homocysteine among Egyptian children before and after nutritional supplementation with the probiotic bacteria Lactobacillus acidophilus in yoghurt matrix","volume":"57","author":"Mohammad MA","year":"2006","unstructured":"Mohammad MA, Molloy A, Scott J, Hussein L. Plasma cobalamin and folate and their metabolic markers methylmalonic acid and total homocysteine among Egyptian children before and after nutritional supplementation with the probiotic bacteria Lactobacillus acidophilus in yoghurt matrix. Int J Food Sci Nutr. 2006, 57:470-80. 10.1080\/09637480600968735","journal-title":"Int J Food Sci Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65842","article-title":"Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis","volume":"123","author":"Liu W","year":"2013","unstructured":"Liu W, Chen Y, Golan MA, et al.. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest. 2013, 123:3983-96. 10.1172\/JCI65842","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.01.007","article-title":"Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals","volume":"69","author":"Luthold RV","year":"2017","unstructured":"Luthold RV, Fernandes GR, Franco-de-Moraes AC, Folchetti LG, Ferreira SR. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals. Metabolism. 2017, 69:76-86. 10.1016\/j.metabol.2017.01.007","journal-title":"Metabolism"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114519003428","article-title":"Effect of time-restricted feeding on metabolic risk and circadian rhythm associated with gut microbiome in healthy males","volume":"123","author":"Zeb F","year":"2020","unstructured":"Zeb F, Wu X, Chen L, et al.. Effect of time-restricted feeding on metabolic risk and circadian rhythm associated with gut microbiome in healthy males. Br J Nutr. 2020, 123:1216-26. 10.1017\/S0007114519003428","journal-title":"Br J Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04601.x","article-title":"Low exposure to sunlight is a risk factor for Crohn's disease","volume":"33","author":"Nerich V","year":"2011","unstructured":"Nerich V, Jantchou P, Boutron-Ruault MC, et al.. Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol Ther. 2011, 33:940-5. 10.1111\/j.1365-2036.2011.04601.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6633","article-title":"Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts","volume":"347","author":"Khalili H","year":"2013","unstructured":"Khalili H, Ananthakrishnan AN, Konijeti GG, et al.. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ. 2013, 347:f6633. 10.1136\/bmj.f6633","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2022.11.030","article-title":"The unpredictability of labile blood pressure: afferent baroreflex failure in a critical patient with multiple thyroid surgeries and COVID-19 infection","volume":"18","author":"Mahmoud A","year":"2023","unstructured":"Mahmoud A, Kania B, Geris S, Akroush W, Manickam R, Azzam MH. The unpredictability of labile blood pressure: afferent baroreflex failure in a critical patient with multiple thyroid surgeries and COVID-19 infection. Radiol Case Rep. 2023, 18:715-8. 10.1016\/j.radcr.2022.11.030","journal-title":"Radiol Case Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.843076","article-title":"Disparity of gut microbiota composition among elite athletes and young adults with different physical activity independent of dietary status: a matching study","volume":"9","author":"Xu Y","year":"2022","unstructured":"Xu Y, Zhong F, Zheng X, Lai HY, Wu C, Huang C. Disparity of gut microbiota composition among elite athletes and young adults with different physical activity independent of dietary status: a matching study. Front Nutr. 2022, 9:843076. 10.3389\/fnut.2022.843076","journal-title":"Front Nutr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/srep35405","article-title":"Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice","volume":"6","author":"Poroyko VA","year":"2016","unstructured":"Poroyko VA, Carreras A, Khalyfa A, et al.. Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice. Sci Rep. 2016, 6:35405. 10.1038\/srep35405","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072304","article-title":"Sleep impairment and psychological distress among patients with inflammatory bowel disease-beyond the obvious","volume":"9","author":"G\u00eelc-Blanariu GE","year":"2020","unstructured":"G\u00eelc-Blanariu GE, \u0218tefnescu G, Trifan AV, et al.. Sleep impairment and psychological distress among patients with inflammatory bowel disease-beyond the obvious. J Clin Med. 2020, 9:2304. 10.3390\/jcm9072304","journal-title":"J Clin Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1586\/eci.10.83","article-title":"Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?","volume":"7","author":"Swanson GR","year":"2011","unstructured":"Swanson GR, Burgess HJ, Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?. Expert Rev Clin Immunol. 2011, 7:29-36. 10.1586\/eci.10.83","journal-title":"Expert Rev Clin Immunol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13342","article-title":"Metformin protects against intestinal barrier dysfunction via AMPK\u03b11-dependent inhibition of JNK signalling activation","volume":"22","author":"Deng J","year":"2018","unstructured":"Deng J, Zeng L, Lai X, Li J, Liu L, Lin Q, Chen Y. Metformin protects against intestinal barrier dysfunction via AMPK\u03b11-dependent inhibition of JNK signalling activation. J Cell Mol Med. 2018, 22:546-57. 10.1111\/jcmm.13342","journal-title":"J Cell Mol Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.577908","article-title":"Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction","volume":"289","author":"Kim J","year":"2014","unstructured":"Kim J, Kwak HJ, Cha JY, Jeong YS, Rhee SD, Kim KR, Cheon HG. Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. J Biol Chem. 2014, 289:23246-55. 10.1074\/jbc.M114.577908","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju AK","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y, et al.. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014, 510:542-6. 10.1038\/nature13270","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1042\/CS20180167","article-title":"Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation","volume":"132","author":"Di Fusco D","year":"2018","unstructured":"Di Fusco D, Dinallo V, Monteleone I, et al.. Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation. Clin Sci (Lond). 2018, 132:1155-68. 10.1042\/CS20180167","journal-title":"Clin Sci (Lond)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.14","article-title":"AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression","volume":"24","author":"Sun X","year":"2017","unstructured":"Sun X, Yang Q, Rogers CJ, Du M, Zhu MJ. AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression. Cell Death Differ. 2017, 24:819-31. 10.1038\/cdd.2017.14","journal-title":"Cell Death Differ"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4236\/crcm.2023.122005","article-title":"Can autoimmune encephalitis occur with negative markers? A rare case report","volume":"12","author":"Mahmoud A","year":"2023","unstructured":"Mahmoud A, Salem A, Nizar Alyassin, Azzam M. Can autoimmune encephalitis occur with negative markers? A rare case report. Case Rep Clin Med. 2023, 12:10.4236\/crcm.2023.122005","journal-title":"Case Rep Clin Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708307","article-title":"The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting","volume":"10","author":"Hall DT","year":"2018","unstructured":"Hall DT, Griss T, Ma JF, et al.. The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting. EMBO Mol Med. 2018, 10:e8307. 10.15252\/emmm.201708307","journal-title":"EMBO Mol Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135858","article-title":"Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17\/Treg balance","volume":"10","author":"Lee SY","year":"2015","unstructured":"Lee SY, Lee SH, Yang EJ, Kim EK, Kim JK, Shin DY, Cho ML. Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17\/Treg balance. PLoS One. 2015, 10:e0135858. 10.1371\/journal.pone.0135858","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa136","article-title":"Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes mellitus","volume":"15","author":"Tseng CH","year":"2021","unstructured":"Tseng CH. Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes mellitus. J Crohns Colitis. 2021, 15:64-73. 10.1093\/ecco-jcc\/jjaa136","journal-title":"J Crohns Colitis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.794103","article-title":"Comparative evaluation of the effect of metformin and insulin on gut microbiota and metabolome profiles of type 2 diabetic rats induced by the combination of streptozotocin and high-fat diet","volume":"12","author":"Hu N","year":"2021","unstructured":"Hu N, Zhang Q, Wang H, Yang X, Jiang Y, Chen R, Wang L. Comparative evaluation of the effect of metformin and insulin on gut microbiota and metabolome profiles of type 2 diabetic rats induced by the combination of streptozotocin and high-fat diet. Front Pharmacol. 2021, 12:794103. 10.3389\/fphar.2021.794103","journal-title":"Front Pharmacol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1177\/1932296815577425","article-title":"Addition of a gastrointestinal microbiome modulator to metformin improves metformin tolerance and fasting glucose levels","volume":"9","author":"Burton JH","year":"2015","unstructured":"Burton JH, Johnson M, Johnson J, Hsia DS, Greenway FL, Heiman ML. Addition of a gastrointestinal microbiome modulator to metformin improves metformin tolerance and fasting glucose levels. J Diabetes Sci Technol. 2015, 9:808-14. 10.1177\/1932296815577425","journal-title":"J Diabetes Sci Technol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.719984","article-title":"Interference with the AMPK\u03b1\/mTOR\/NLRP3 signaling and the IL-23\/IL-17 axis effectively protects against the dextran sulfate sodium intoxication in rats: a new paradigm in empagliflozin and metformin reprofiling for the management of ulcerative colitis","volume":"12","author":"Youssef ME","year":"2021","unstructured":"Youssef ME, Abd El-Fattah EE, Abdelhamid AM, et al.. Interference with the AMPK\u03b1\/mTOR\/NLRP3 signaling and the IL-23\/IL-17 axis effectively protects against the dextran sulfate sodium intoxication in rats: a new paradigm in empagliflozin and metformin reprofiling for the management of ulcerative colitis. Front Pharmacol. 2021, 12:719984. 10.3389\/fphar.2021.719984","journal-title":"Front Pharmacol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100979","article-title":"GLP-1 based therapies and disease course of inflammatory bowel disease","volume":"37","author":"Villumsen M","year":"2021","unstructured":"Villumsen M, Schelde AB, Jimenez-Solem E, Jess T, Allin KH. GLP-1 based therapies and disease course of inflammatory bowel disease. EClinicalMedicine. 2021, 37:100979. 10.1016\/j.eclinm.2021.100979","journal-title":"EClinicalMedicine"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-019-01698-z","article-title":"Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives","volume":"392","author":"Zatorski H","year":"2019","unstructured":"Zatorski H, Sa\u0142aga M, Fichna J. Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives. Naunyn Schmiedebergs Arch Pharmacol. 2019, 392:1321-30. 10.1007\/s00210-019-01698-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2019.05.008","article-title":"Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice","volume":"44","author":"Ryan PM","year":"2020","unstructured":"Ryan PM, Patterson E, Carafa I, et al.. Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice. Can J Diabetes. 2020, 44:146-155.e2. 10.1016\/j.jcjd.2019.05.008","journal-title":"Can J Diabetes"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41559","article-title":"Understanding the role of the gut microbiome in diabetes and therapeutics targeting leaky gut: a systematic review","volume":"15","author":"Sadagopan A","year":"2023","unstructured":"Sadagopan A, Mahmoud A, Begg M, et al.. Understanding the role of the gut microbiome in diabetes and therapeutics targeting leaky gut: a systematic review. Cureus. 2023, 15:e41559. 10.7759\/cureus.41559","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159929-inflammatory-bowel-sugar-disease-a-pause-from-new-pharmacological-agents-and-an-embrace-of-natural-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:20Z","timestamp":1707509000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159929-inflammatory-bowel-sugar-disease-a-pause-from-new-pharmacological-agents-and-an-embrace-of-natural-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.42786","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}